Carboplatin-, Oxaliplatin-, and Cisplatin-specific IgE: Cross-reactivity and Value in the Diagnosis of Carboplatin and Oxaliplatin Allergy

Journal of Allergy and Clinical Immunology: In Practice

Volumn 1, Issue 5, 2013, Pages 494-500

  Caiado, Joana ^a   Venemalm, Lennart ^b   Pereira Santos, Maria Conceição ^c   Costa, Luis ^a   Barbosa, Manuel Pereira ^a   Castells, Mariana ^d  

^a HOSPITAL DE SANTA MARIA   (Portugal)

^b Thermo Fisher Scientific   (United States)

^c Lisbon Medical School   (Portugal)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Carboplatin; Cross reactivity; Oxaliplatin; Platin hypersensitivity; Platin specific IgE; Skin testing

Indexed keywords

CARBOPLATIN; CISPLATIN; IMMUNOGLOBULIN E; OXALIPLATIN; ANTINEOPLASTIC AGENT; PLATINUM COMPLEX;

ADULT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; CHEMOSENSITIVITY; CLINICAL ARTICLE; COLON CANCER; CONTROLLED STUDY; DRUG CROSS REACTIVITY; DRUG EXPOSURE; DRUG HYPERSENSITIVITY; DRUG STRUCTURE; DRUG TOLERABILITY; ENDOMETRIUM CANCER; FEMALE; HUMAN; IMMUNOGENICITY; MALE; OVARY CANCER; PANCREAS CANCER; PREDICTIVE VALUE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SKIN TEST; AGED; BLOOD; CROSS REACTION; IMMUNOLOGY; MIDDLE AGED;

AGED; ANTINEOPLASTIC AGENTS; CARBOPLATIN; CISPLATIN; CROSS REACTIONS; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; SKIN TESTS;

EID: 84883326695     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2013.06.002     Document Type: Article

References (31)

1. Khan D.A., Solensky R. Drug allergy. JAllergy Clin Immunol 2010, 125(Suppl 2):S126-S137.
2. Lenz H.J. Management and preparedness for infusion and hypersensitivity reactions. Oncologist 2007, 12:601-609.
3. Sliesoraitis S., Chikhale P.J. Carboplatin hypersensitivity. Int J Gynecol Cancer 2005, 15:13-18.
4. Castells M. Rapid desensitization for hypersensitivity reactions to chemotherapy agents. Curr Opin Allergy Clin Immunol 2006, 6:271-277.
5. Markman M., Zanotti K., Peterson G., Kulp B., Webster K., Belinson J. Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity. JClin Oncol 2003, 21:4611-4614.
6. Castells M.C., Tennant N.M., Sloane D.E., Hsu F.I., Barrett N.A., Hong D.I., et al. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. JAllergy Clin Immunol 2008, 122:574-580.
7. Leguy-Seguin V., Jolimoy G., Coudert B., Pernot C., Dalac S., Vabres P., et al. Diagnostic and predictive value of skin testing in platinum salt hypersensitivity. JAllergy Clin Immunol 2007, 119:726-730.
8. Zanotti K.M., Markman M. Prevention and management of antineoplastic-induced hypersensitivity reactions. Drug Saf 2001, 24:767-779.
9. Patil S.U., Long A.A., Ling M., Wilson M.T., Hesterberg P., Wong J.T., et al. Aprotocol for risk stratification of patients with carboplatin-induced hypersensitivity reactions. JAllergy Clin Immunol 2012, 129:443-447.
10. Hesterberg P.E., Banerji A., Oren E., Penson R.T., Krasner C.N., Seiden M.V., et al. Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management. JAllergy Clin Immunol 2009, 123:1262-1267.
11. André M.C., Silva R., Filipe P.L., Lopes A., Soares de Almeida L.M. Systemic contact allergy to penicillin after prick and intradermal tests. Ann Allergy Asthma Immunol 2011, 106:174-175.
12. Weber-Mani U., Pichler W.J. Anaphylactic shock after intradermal testing with betalactam antibiotics. Allergy 2008, 63:785.
13. Makris M.P., Koulouris S., Kalogeromitros D. Nonimmediate systemic hypersensitivity reaction to beta-lactam intradermal tests. JInvestig Allergol Clin Immunol 2010, 20:630-631.
14. Bagg A., Chacko T., Lockey R. Reactions to prick and intradermal skin tests. Ann Allergy Asthma Immunol 2009, 102:400-402.
15. Kränke B., Aberer W. Skin testing for IgE-mediated drug allergy. Immunol Allergy Clin North Am 2009, 29:503-516.
16. Couto M., Gaspar A., Piedade S., Arêde C., Menezes M., Sousa M.J., et al. IgE-mediated metamizol allergy and the usefulness of the cellular allergen stimulation test. Eur Ann Allergy Clin Immunol 2012, 44:113-116.
17. Viola M., Quaratino D., Gaeta F., Valluzzi R.L., Caruso C., Rumi G., et al. Allergic reactions to antibiotics, mainly betalactams: facts and controversies. Eur Ann Allergy Clin Immunol 2005, 37:223-229.
18. Prematta T., Shah S., Ishmael F.T. Physician approaches to beta-lactam use in patients with penicillin hypersensitivity. Allergy Asthma Proc 2012, 33:145-151.
19. Torres M.J., Blanca M. The complex clinical picture of beta-lactam hypersensitivity: penicillins, cephalosporins, monobactams, carbapenems, and clavams. Med Clin North Am 2010, 94:805-820.
20. Pagani M., Venemalm L., Bonnadona P., Vescovi P.P., Botelho C., Cernadas J.R. An experimental biological test to diagnose hypersensitivity reactions to carboplatin:new horizons for an old problem. Jpn J Clin Oncol 2012, 42:347-350.
21. Caiado J., Pereira-Santos M.C., Venenalm L., Costa L., Pedro E., Barbosa M., et al. In vitro diagnosis in hypersensitivity to platins. Allergy 2011, 66(Suppl 94). 5-6 [abstract].
22. Brown S.G. Clinical features and severity grading of anaphylaxis. JAllergy Clin Immunol 2004, 114:371-376.
23. Zanotti K.M., Rybicki L.A., Kennedy A.W., Belinson J.L., Webster K.D., Kulp B., et al. Carboplatin skin testing: a skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapy. JClin Oncol 2001, 19:3126-3129.
24. Garufi C., Cristaudo A., Vanni B., Bria E., Aschelter A.M., Santucci B., et al. Skin testing and hypersensitivity reactions to oxaliplatin. Ann Oncol 2003, 14:497-498.
25. Pagani M., Bonadonna P., Senna G.E., Antico A. Standardization of skin tests for diagnosis and prevention of hypersensitivity reactions to oxaliplatin. Int Arch Allergy Immunol 2008, 145:54-57.
26. Knol E.F., Knust A.C. Application of multiplexed immunoglobulin E determination on a chip in component resolved diagnosis. Clin Exp Allergy 2010, 40:190-192.
27. Turcanu V. Could T cell component-resolved diagnosis differentiate between food sensitization and food allergy?. Clin Exp Allergy 2010, 40:531-533.
28. Nicolaou N., Poorafshar P.M., Murray C. Allergy or tolerance in children sensitized to peanut: prevalence and differentiation using component-resolved diagnostics. JAllergy Clin Immunol 2010, 125:191-197.
29. Casquete-Román E., Rosado-Gil T., Postigo I., Guisantes J.A., Fernández M., Torres H.E., et al. Profilin cross-reactive panallergen causes latex sensitization in the pediatric population allergic to pollen. Ann Allergy Asthma Immunol 2012, 109:215-219.
30. Enrique E., Malek T., Castelló J.V., de Mateo J.A. Usefulness of skin testing with platinum salts to demonstrate lack of cross-reactivity between carboplatin and cisplatin. Ann Allergy Asthma Immunol 2008, 100:86.
31. Meyer L., Zuberbier T., Worm M., Oettle H., Riess H. Hypersensitivity reactions to oxaliplatin: cross-reactivity to carboplatin and the introduction of a desensitization schedule. JClin Oncol 2002, 20:1146-1147.